Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN1042587 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-CD34 Molecule (CD34) antibody
- Antibody type
- Monoclonal
- Description
- Protein A affinity chromatography
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- QBEND-10
- Vial size
- 0.1 mL
Submitted references Endosialin (CD248) is a marker of tumor-associated pericytes in high-grade glioma.
CD34 immunohistochemical assessment of angiogenesis as a prognostic marker for prostate cancer recurrence after radical prostatectomy.
Incidence and prognostic relevance of CD34 expression in acute myeloblastic leukemia: analysis of 141 cases.
QBEND/10, a new monoclonal antibody to endothelium: assessment of its diagnostic utility in paraffin sections.
Simonavicius N, Robertson D, Bax DA, Jones C, Huijbers IJ, Isacke CM
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2008 Mar;21(3):308-15
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2008 Mar;21(3):308-15
CD34 immunohistochemical assessment of angiogenesis as a prognostic marker for prostate cancer recurrence after radical prostatectomy.
Bettencourt MC, Bauer JJ, Sesterhenn IA, Connelly RR, Moul JW
The Journal of urology 1998 Aug;160(2):459-65
The Journal of urology 1998 Aug;160(2):459-65
Incidence and prognostic relevance of CD34 expression in acute myeloblastic leukemia: analysis of 141 cases.
Raspadori D, Lauria F, Ventura MA, Rondelli D, Visani G, de Vivo A, Tura S
Leukemia research 1997 Jul;21(7):603-7
Leukemia research 1997 Jul;21(7):603-7
QBEND/10, a new monoclonal antibody to endothelium: assessment of its diagnostic utility in paraffin sections.
Ramani P, Bradley NJ, Fletcher CD
Histopathology 1990 Sep;17(3):237-42
Histopathology 1990 Sep;17(3):237-42
No comments: Submit comment
No validations: Submit validation data